Nodular scleritis and panuveitis with erythema elevatum diutinum.

Y. Mitamura,Osamutaro Fujiwara,K. Miyanishi,Hiroko Sato,K. Saga,K. Ohtsuka

DOI: https://doi.org/10.1016/S0002-9394(03)00907-3

2004-02-01

Abstract:

What problem does this paper attempt to address?

Photo and Redox Dual Responsive Reversibly Cross-Linked Nanocarrier for Efficient Tumor-Targeted Drug Delivery

Yu Shao,Changying Shi,Gaofei Xu,DanDan Guo,Juntao Luo

DOI: https://doi.org/10.1021/am501913m

IF: 9.5

2014-01-01

ACS Applied Materials & Interfaces

Abstract:To develop a feasible and efficient nanocarrier for potential clinical application, a series of photo and redox dual responsive reversibly cross-linked micelles have been developed for the targeted anticancer drug delivery. The nanocarrier can be cross-linked efficiently via a clean, efficient, and controllable coumarin photodimerization within the nanocarrier, which simplify the formulation process and quality control prior clinical use and improve the in vivo stability for tumor targeting. At the same time, cross-linking of nanocarrier could be cleaved via the responsiveness of the built-in disulfide cross-linkage to the redox tumor micro-environment for on-demand drug release. Coumarin and disulfide bond was introduced into a linear-dendritic copolymer (named as telodendrimer) precisely via peptide chemistry. The engineered nanocarrier possesses good drug loading capacity and stability, and exhibits a safer profile as well as similar anticancer effects compared with free drug in cell culture. The in vivo and ex vivo small animal imaging revealed the preferred tumor accumulation and the prolonged tumor residency of the payload delivered by the cross-linked micelles compared to the non-cross-linked micelles and free drug surrogate because of the increased stability.
Photodynamic‐Chemodynamic Cascade Reactions for Efficient Drug Delivery and Enhanced Combination Therapy

Sheng Wang,Guocan Yu,Weijing Yang,Zhantong Wang,Orit Jacobson,Rui Tian,Hongzhang Deng,Lisen Lin,Xiaoyuan Chen

DOI: https://doi.org/10.1002/advs.202002927

IF: 15.1

2021-01-01

Advanced Science

Abstract:AbstractNanomedicines with photodynamic therapy and reactive oxygen species (ROS)‐triggered drug release capabilities are promising for cancer therapy. However, most of the nanomedicines based on ROS‐responsive nanocarriers still suffer from serious ROS consumption during the triggered drug release process. Herein, a photodynamic‐chemodynamic cascade strategy for the design of drug delivery nanosystem is proposed. A doxorubicin hydrochloride‐loaded ROS‐responsive polymersome (DOX‐RPS) is prepared via the self‐assembly of amphiphilic poly(ethylene glycol)‐poly(linoleic acid) and poly(ethylene glycol)‐(2‐(1‐hexyloxyethyl)‐2‐devinyl pyropheophorbide‐α)‐iron chelate (PEG‐HPPH‐Fe). The RPS can effectively deliver a drug to tumor site through passive targeting effect. Upon laser irradiation, the photosensitizer HPPH can efficiently generate ROS, which further causes in situ oxidation of linoleic acid chain and subsequent RPS structural destruction, permitting triggered drug release. Intriguingly, catalyzed by HPPH‐Fe, ROS will be regenerated from linoleic acid peroxide through a chemodynamic process. Therefore, ROS‐triggered drug release can be achieved without ROS over‐consumption. The in vitro and in vivo results confirmed ROS generation, triggered drug release behavior, and potent antitumor effect of the DOX‐RPS. This photodynamic‐chemodynamic cascade strategy provides a promising approach for enhanced combination therapy.
Dual‐Targeting Photosensitizer‐Peptide Amphiphile Conjugate for Enzyme‐Triggered Drug Delivery and Synergistic Chemo‐Photodynamic Tumor Therapy

Yin‐Jia Cheng,Si‐Yong Qin,Wen‐Long Liu,Yi‐Han Ma,Xiao‐Sui Chen,Ai‐Qing Zhang,Xian‐Zheng Zhang

DOI: https://doi.org/10.1002/admi.202000935

IF: 5.4

2020-08-19

Advanced Materials Interfaces

Abstract:Chemo‐photodynamic therapy is an attractive strategy in tumor treatment. However, the combination of chemotherapeutic drug and photosensitizer in nanocarriers always elevates the risk of composition uncertainty. Here, a dual‐targeting photosensitizer‐peptide amphiphile conjugate (PpIX‐GGGK(TPP)GG‐GFLG‐R7‐RGD or pPAC) is designed to encapsulate doxorubicin (DOX) for enhanced chemo‐photodynamic tumor therapy. The amphiphilic nature of pPAC leads to the formation of core‐shell structured nanomicelles in aqueous media, where DOX is loaded in the inner core. The DOX@pPAC nanomicelle displays efficient tumor cellular uptake via integrin receptor‐mediated endocytosis using RGD peptide. After successful cell internalization with the aid of R8 peptide, DOX@pPAC exhibits rapid release of DOX and protoporphyrin IX‐peptide conjugate (PpIX‐peptide) due to the Cathepsin B‐triggered hydrolysis of GFLG linker. Simultaneously, triphenylphosphonium TPP cation will accumulate photosensitizer PpIX in subcellular mitochondria, followed by in situ generation of phototoxic reactive oxygen species (ROS) under light irradiation. In vitro investigations demonstrate that the synergistic chemotherapy and photodynamic therapy (PDT) of fabricated nanomicelles can significantly maximize the therapeutic effect against tumor cells with the minimal off‐target cytotoxicity. This work may provide an all‐in‐one nanosystem toward enhanced chemo‐photodynamic tumor therapy.

materials science, multidisciplinary,chemistry
Novel construction of multifunctional photo-responsive and nucleic acid-triggered doxorubicin-releasing liposomes for cancer therapy

Xinxin Liu,Liying Meng,Zheyi Wang,Zongjiang Yu,Chen Zhang,Limin Liu,Zen Coen,Zhongjun Yang,Guanzhao Wu

DOI: https://doi.org/10.1016/j.ejmech.2023.115207

2023-03-15

Abstract:All-in-one nano theranostics integrating accurate diagnosis and combined therapy is promising for high-efficacy tumor treatment and receiving significant attention. In this study, we develop photo-controlled release liposomes with nucleic acid-triggered fluorescence and photoactivity for tumor imaging and synergistic antitumor therapy. Copper phthalocyanine as a photothermal agent is fused into lipid layers to prepare liposomes encapsulating cationic zinc phthalocyanine ZnPc(TAP)412+ and doxorubicin, followed by the modification of RGD peptide on the surface to obtain the final product RGD-CuPc:ZnPc(TAP)412+:DOX@LiPOs (RCZDL). RCZDL possesses favorable stability, significant photothermal effect, and photo-controlled release function through the characterization of physicochemical properties. It is shown that the fluorescence and ROS generation could be turned on by intracellular nucleic acid after illumination. RCZDL exhibits synergistic cytotoxicity, increased apoptosis, and significantly promoted cell uptake. Subcellular localization analysis indicates that ZnPc(TAP)412+ tends to be distributed in the mitochondria of HepG2 cells treated with RCZDL after exposure to light. The results of experiments in vivo on H22 tumor-bearing mice demonstrate that RCZDL had excellent tumor targeting, a prominent photothermal effect at the tumor sites, and synergistic antitumor efficiency. More importantly, little RCZDL has been found to be accumulated in the liver, and most were quickly metabolized by the liver. The results confirm that the proposed new intelligent liposomes provide a simple and cost-effective way for tumor imaging and combinatorial anticancer therapy.
The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications.

D. Kirkpatrick,S. Gerber,S. Gygi

DOI: https://doi.org/10.1016/J.YMETH.2004.08.018

IF: 4.647

2005-03-01

Methods

Abstract:
Photo-Responsive Supramolecular Micelles for Controlled Drug Release and Improved Chemotherapy

Fasih Bintang Ilhami,Kai-Chen Peng,Yi-Shiuan Chang,Yihalem Abebe Alemayehu,Hsieh-Chih Tsai,Juin-Yih Lai,Yu-Hsuan Chiao,Chen-Yu Kao,Chih-Chia Cheng

DOI: https://doi.org/10.3390/ijms22010154

IF: 5.6

2020-12-25

International Journal of Molecular Sciences

Abstract:Development of stimuli-responsive supramolecular micelles that enable high levels of well-controlled drug release in cancer cells remains a grand challenge. Here, we encapsulated the antitumor drug doxorubicin (DOX) and pro-photosensitizer 5-aminolevulinic acid (5-ALA) within adenine-functionalized supramolecular micelles (A-PPG), in order to achieve effective drug delivery combined with photo-chemotherapy. The resulting DOX/5-ALA-loaded micelles exhibited excellent light and pH-responsive behavior in aqueous solution and high drug-entrapment stability in serum-rich media. A short duration (1–2 min) of laser irradiation with visible light induced the dissociation of the DOX/5-ALA complexes within the micelles, which disrupted micellular stability and resulted in rapid, immediate release of the physically entrapped drug from the micelles. In addition, in vitro assays of cellular reactive oxygen species generation and cellular internalization confirmed the drug-loaded micelles exhibited significantly enhanced cellular uptake after visible light irradiation, and that the light-triggered disassembly of micellar structures rapidly increased the production of reactive oxygen species within the cells. Importantly, flow cytometric analysis demonstrated that laser irradiation of cancer cells incubated with DOX/5-ALA-loaded A-PPG micelles effectively induced apoptotic cell death via endocytosis. Thus, this newly developed supramolecular system may offer a potential route towards improving the efficacy of synergistic chemotherapeutic approaches for cancer.

biochemistry & molecular biology,chemistry, multidisciplinary
Photoresponsive Prodrug‐dye Nanoassembly for In‐situ Monitorable Cancer Therapy

Kaiqi Long,Yifan Wang,Wen Lv,Yang,Shuting Xu,Changyou Zhan,Weiping Wang

DOI: https://doi.org/10.1002/btm2.10311

2022-01-01

Bioengineering & Translational Medicine

Abstract:Abstract Photocleavable prodrugs enable controllable drug delivery to target sites modulated by light irradiation. However, the in vivo utility is usually hindered by their insolubility and inefficient delivery. In this study, we report a simple strategy of co‐assembling boron‐dipyrromethene‐chlorambucil prodrug and near‐infrared dye IR783 to fabricate photoresponsive nanoassemblies, which achieved both high prodrug loading capacity (~99%) and efficient light‐triggered prodrug activation. The incorporated IR783 dye not only stabilized the nanoparticles and contributed tumor targeting as usual, but also exhibited degradation after light irradiation and in‐situ monitoring of nanoparticle dissociation by fluorescent imaging. Systemic administration of the nanoparticles and localized light irradiation at tumor sites enabled monitorable and efficient drug release in vivo. Our results demonstrate that such prodrug‐dye co‐assembled nanomedicine is a promising formulation for photoresponsive drug delivery, which would advance the translation of photoresponsive nanomedicines.
Photo Synthesis of Protein-Based Drug-Delivery Nanoparticles for Active Tumor Targeting.

Jinbing Xie,Ying Li,Yi Cao,Chun Xu,Mao Xia,Meng Qin,Jiwu Wei,Wei Wang

DOI: https://doi.org/10.1039/c3bm60174a

IF: 3.036

2015-01-01

Annals of Physics

Abstract:Recently, nanometer-sized drug-delivery systems (DDSs) with an active targeting function to tumor sites have been cinfirmed to have great efficiency for cancer chemotherapy. However, the use of complicated modification techniques and the poor graft efficiency of the targeting ligands on the surface of the DDS have largely limited the application of most of the nano-DDSs. Especially for protein-based nano-DDSs, grafting of targeting ligands often requires genetic modification of the protein sequences, which is laborious and inefficient. Here, we present a novel method to photo synthesize a protein-based drug-delivery system with an active targeting function to tumor sites. The disulfide bonds in protein bovine α-lactalbumin (BLA) can be ruptured by controlled UV illumination, which triggers the formation of nano-sized protein aggregates and releases free thiol groups for the modification of the active targeting ligand of circular RGD peptide. Moreover, we demonstrated that the anti-cancer drug doxorubicin (DOX) can be loaded onto the protein-based DDS during the photo synthesis step. The synthesis approach is very convenient and cost-effective and can be accomplished under physiological conditions. Both in vitro and in vivo experiments validate that this DDS system possesses a much greater drug-delivery efficiency to the tumor sites and a better inhibition capability of tumor growth than the unmodified counterparts. This novel drug-delivery system can find broad applications in cancer chemotherapy. Moreover, our synthetic strategy can be easily extended to other disulfide-containing proteins and greatly expand the tool-box of protein-based DDSs for active targeting.
Photosensitizer-stabilized Self-Assembling Nanoparticles Potentiate Chemo/photodynamic Efficacy of Patient-Derived Melanoma.

Lingling Huang,Xiaona Chen,Qiong Bian,Fu Zhang,Honghui Wu,Hangxiang Wang,Jianqing Gao

DOI: https://doi.org/10.1016/j.jconrel.2020.08.062

IF: 11.467

2020-01-01

Journal of Controlled Release

Abstract:Development of injectable nanoparticles for delivery of active anticancer compounds often requires complicated schemes that involve tedious synthetic protocols and nanoformulations. In particular, clinical translation of synergistic nanoparticles that can facilitate multimodal therapies remains a considerable challenge. Herein, we describe a self-assembling, small-molecule nanosystem with unique properties, including near-infrared (NIR) light-responsive drug activation, size transformability, combinatorial synergy, and substantially reduced toxicity. Ligation of anticancer cabazitaxel (CTX) drugs via a reactive oxygen species-activatable thioketal linkage generates a dimeric TKdC prodrug, and subsequent coassembly with a photosensitizer, chlorin e6 (Ce6), forms colloidal-stable nanoassemblies (termed psTKdC NAs). Upon NIR laser irradiation, psTKdC NAs are transformed into smaller size particles and facilitate production of pharmacologically active CTX. Importantly, reactive oxygen species yielded by coassembled Ce6 can synergize with chemotherapy to achieve potent combinatorial effects. In a preclinical orthotopic model of an aggressive, human melanoma patient-derived xenograft (PDX), we show that administration of psTKdC NAs followed by laser irradiation produced durable tumor regression, with the tumors being completely eradicated in three of six PDXs. Furthermore, low systemic toxicity of this smart, photo-activatable nanotherapy was observed in animals. The new self-deliverable combinatorial system addresses essential requirements for high efficacy, safety, and translational capacity and deserves further investigation.
CD44-Targeted Photoactivatable Polymeric Nanosystem with On-Demand Drug Release as a "Photoactivatable Bomb" for Combined Photodynamic Therapy-Chemotherapy of Cancer

Jin-Shuai Lan,Rui-Feng Zeng,Zhe Li,Ya Wu,Li Liu,Li-Xia Chen,Yun Liu,Yi-Tian He,Tong Zhang,Yue Ding

DOI: https://doi.org/10.1021/acsami.3c05645

IF: 9.5

2023-07-19

ACS Applied Materials & Interfaces

Abstract:Nowadays, the combined use of chemotherapy and photodynamic therapy (PDT) remains the most popular strategy for cancer treatment with high theraprutic efficacy. However, targeted therapy with the on-demand release of drugs is what most clinical treatments lack, leading to heavy side effects. Herein, a new CD44-targeted and red-light-activatable nanosystem, Ru-HA@DOX nanoparticles (NPs), was developed by conjugating hydrophilic biodegradable hyaluronic acid (HA) and hydrophobic photoresponsive...

materials science, multidisciplinary,nanoscience & nanotechnology
Photon-manipulated Drug Release from a Mesoporous Nanocontainer Controlled by Azobenzene-Modified Nucleic Acid.

Quan Yuan,Yunfei Zhang,Tao Chen,Danqing Lu,Zilong Zhao,Xiaobing Zhang,Zhenxing Li,Chun-Hua Yan,Weihong Tan

DOI: https://doi.org/10.1021/nn3018365

IF: 17.1

2012-01-01

ACS Nano

Abstract:Herein a photon-manipulated mesoporous release system was constructed based on azobenzene-modified nucleic acids. In this system, the azobenzene-incorporated DNA double strands were immobilized at the pore mouth of mesoporous silica nanoparticles. The photoisomerization of azobenzene induced dehybridization/hybridization switch of complementary DNA, causing uncapping/capping of pore gates of mesoporous silica. This nanoplatform permits holding of guest molecules within the nanopores under visible light but releases them when light wavelength turns to the UV range. These DNA/mesoporous silica hybrid nanostructures were exploited as carriers for the cancer cell chemotherapy drug doxorubicin (DOX) due to its stimuli-responsive property as well as good biocompatibility via MTT assay. It is found that the drug release behavior is light-wavelength-sensitive. Switching of the light from visible to the UV range uncapped the pores, causing the release of DOX from the mesoporous silica nanospheres and an obvious cytotoxic effect on cancer cells. We envision that this photocontrolled drug release system could find potential applications in cancer therapy.
MMP-2 and Upconverted UV Dual-Mediated Drug Sequential Delivery and On-Site Immobilization for Enhanced Multidrug-Resistant Cancer Therapy

Anna Wang,Jing Fang,Yali Feng,Yuqi Zhang,Yan Zhao,Jiachen Li,Chaoxiang Cui,Yi Hou,Haibin Shi,Mingyuan Gao

DOI: https://doi.org/10.1007/s11426-023-1606-8

2023-01-01

Science China Chemistry

Abstract:Controlled drug delivery holds great potential for effective tumor treatment owing to the merits of overcoming drug resistance and improving therapeutic efficacy while minimizing systemic toxicity. However, accurate and controllable delivery of chemotherapeutics into tumor tissue with high efficiency remains a huge challenge. Taking advantage of the UV-emitting characteristics of upconversion nanoparticles (UCNPs), herein we for the first time in-situ immobilization (ENDDI) system that is fabricated by decorating UCNPs with MMP-2 responsive and photocrosslinkable peptide bearing anticancer drug doxorubicin (DOX) for overcoming multidrug resistance. Upon cleavage with tumor-specific MMP-2, the peptide fragment containing a photolabile benzophenone (BP) and DOX could be released and in-situ immobilized within the tumor through the covalent crosslinking reaction between BP and neighboring biomolecules under the excitation of converted UV emission from UCNPs, which remarkably blocks the exocytosis of DOX leading to prolonged drug retention, achieving significant suppression of DOX-resistant breast tumors. Our current dual stimuli-mediated sequential drug delivery and in-situ immobilization represent a generalizable strategy for the effective treatment of multidrug resistant tumors.
Dual-responsive Doxorubicin-Loaded Nanomicelles for Enhanced Cancer Therapy.

Zhang Xinyi,Zhu Tiantian,Miao Yaxin,Zhou Lu,Zhang Weifang

DOI: https://doi.org/10.1186/s12951-020-00691-6

IF: 10.2

2020-01-01

Journal of Nanobiotechnology

Abstract:BACKGROUND:The enhancement of tumor retention and cellular uptake of drugs are important factors in maximizing anticancer therapy and minimizing side effects of encapsulated drugs. Herein, a delivery nanoplatform, armed with a pH-triggered charge-reversal capability and self-amplifiable reactive oxygen species (ROS)-induced drug release, is constructed by encapsulating doxorubicin (DOX) in pH/ROS-responsive polymeric micelle.RESULTS:The surface charge of this system was converted from negative to positive from pH 7.4 to pH 6.8, which facilitated the cellular uptake. In addition, methionine-based system was dissociated in a ROS-rich and acidic intracellular environment, resulting in the release of DOX and α-tocopheryl succinate (TOS). Then, the exposed TOS segments further induced the generation of ROS, leading to self-amplifiable disassembly of the micelles and drug release.CONCLUSIONS:We confirms efficient DOX delivery into cancer cells, upregulation of tumoral ROS level and induction of the apoptotic capability in vitro. The system exhibits outstanding tumor inhibition capability in vivo, indicating that dual stimuli nano-system has great potential to function as an anticancer drug delivery platform.
Acid-sensitive polymeric prodrug micelles for achieving enhanced chemo-photodynamic therapy

Jianyong Du,Xiaoqing Liu,Zhongkai Hou,Xin Liu,Jinzhu Yao,Xu Cheng,Xin Wang,Rupei Tang

DOI: https://doi.org/10.1016/j.jddst.2022.103514

IF: 5

2022-08-01

Journal of Drug Delivery Science and Technology

Abstract:Multimodal combination therapy is considered more effective in cancer treatment than monotherapy, because it overcomes some limitations of monotherapy. In this study, acid-sensitive polymeric prodrugs consisting of photosensitizer (Hemin) and ortho ester-terminated PEG were synthesized and loaded with doxorubicin (DOX) to obtain a dual-modal therapeutic nanoplatform (Hemin/DOX-M). This nanoplatform demonstrated good drug encapsulation and stability. In vitro experiments have confirmed that Hemin/DOX-M can be effectively internalized by HepG2 cells, trigger rapid drug release via the cleavage of ortho ester and alleviate tumor hypoxia to amplify the PDT effect under laser irradiation. In vivo experiments revealed that Hemin/DOX-M caused decreased hemolysis and selective accumulation in the tumor tissue, thereby significantly reducing the side effects. Intriguingly, In vivo antitumor evaluation revealed that Hemin/DOX-M had stronger capability at tumor growth inhibition (TGI, 79.63%) than chemo- or photodynamic therapy alone. Overall, Hemin/DOX-M is a promising candidate to increase therapeutic efficacy by achieving combination therapy against tumors.

pharmacology & pharmacy
Photoactivatable Sequential Destruction of Multiorganelles for Cancer Therapy

Wenping Pan,Hongwei Shao,Limin Ma,Xubo Tong,Zicong Zhang,Qian Li,Xin Yang,Kai Liu,Meng Gao,Yingjun Wang

DOI: https://doi.org/10.1021/acsami.3c04070

IF: 9.5

2023-08-02

ACS Applied Materials & Interfaces

Abstract:Organelle-targeted therapy guided by fluorescence imaging is promising for precise cancer treatment. However, most current organelle-targeted therapeutics can only destruct single organelles, which suffer from limited therapeutic efficacy. To address this challenge, a photoactivatable probe was developed for sequential photodynamic destruction of multiorganelles in cancer cells, including lysosomes, lipid droplets, and mitochondria. This photoactivatable probe not only exhibits efficient cancer...

materials science, multidisciplinary,nanoscience & nanotechnology
Oxidation-strengthened disulfide-bridged prodrug nanoplatforms with cascade facilitated drug release for synergetic photochemotherapy

Bin Yang,Lin Wei,Yuequan Wang,Na Li,Bin Ji,Kaiyuan Wang,Xuanbo Zhang,Shenwu Zhang,Shuang Zhou,Xiaohui Yao,Hang Song,Yusheng Wu,Haotian Zhang,Qiming Kan,Tao Jin,Jin Sun

DOI: https://doi.org/10.1016/j.ajps.2019.09.001

IF: 9.273

2020-09-01

Asian Journal of Pharmaceutical Sciences

Abstract:One of the major barriers in utilizing prodrug nanocarriers for cancer therapy is the slow release of parent drug in tumors. Tumor cells generally display the higher oxidative level than normal cells, and also displayed the heterogeneity in terms of redox homeostasis level. We previously found that the disulfide bond-linkage demonstrates surprising oxidation-sensitivity to form the hydrophilic sulfoxide and sulphone groups. Herein, we develop oxidation-strengthened prodrug nanosystem loaded with pyropheophorbide a (PPa) to achieve light-activatable cascade drug release and enhance therapeutic efficacy. The disulfide bond-driven prodrug nanosystems not only respond to the redox-heterogeneity in tumor, but also respond to the exogenous oxidant (singlet oxygen) elicited by photosensitizers. Once the prodrug nanoparticles (NPs) are activated under irradiation, they would undergo an oxidative self-strengthened process, resulting in a facilitated drug cascade release. The IC50 value of the PPa@PTX-S-S NPs without irradiation was 2-fold higher than those of NPs plus irradiation. In vivo, the PPa@PTX prodrug NPs display prolonged systemic circulation and increased accumulation in tumor site. The PPa@PTX-S-S NPs showed much higher efficiency than free PTX or the PPa@PTX-C-C NPs to suppress the growth of 4T1 tumors. Therefore, this novel oxidation-strengthened disulfide-bridged prodrug-nanosystem has a great potential in the enhanced efficacy of cancer synergetic photochemotherapy.Firstly, the prodrug nanosystems containing disulfide bond could realize chemo-photodynamic therapy in response to the endogenous and endogenous ROS concentration, leading to an obvious cytotoxicity in cancer cells. Secondly, the PPa@PTX prodrug NPs display prolonged systemic circulation and increased accumulation in tumor site. Lastly, the in vivo antitumor efficiency demonstrated that the oxidation-strengthened PPa@PTX prodrug NPs efficiently inhibit the growth of 4T1 tumors. (A) The self-assembly process of disulfide bond-driven prodrug NPs; (B) Schematic illustration of prodrug NPs displayed light-activated fast drug release and chemo-photodynamic therapy. 

pharmacology & pharmacy
A Nanomedicine Composed of Polymer- ss -DOX and Polymer-Ce6 Prodrugs with Monoclonal Antibody Targeting Effect for Anti-tumor Chemo-Photodynamic Synergetic Therapy

Liang Yu,Mingzu Zhang,Jinlin He,Xingwei Sun,Peihong Ni

DOI: https://doi.org/10.1016/j.actbio.2024.02.048

IF: 10.633

2024-03-09

Acta Biomaterialia

Abstract:Anticancer drugs used for systemic chemotherapy often exhibit off-target toxicity and uncontrolled drug release due to their lack of targeting. To improve the bioavailability of drugs and reduce side effects, we have developed a mixed micelle of nanomedicine composed of two prodrugs with surface modified monoclonal antibody for cancer therapy. In this system, Nimotuzumab was used as targeting ligands of the mixed micelles (named as DCMMs) that is composed of polymer-doxorubicin prodrug (abbreviated as PEG- b -P(GMA- ss -DOX)) and maleimide polyethylene glycol-chlorin e6 (abbreviated as Mal-PEG-Ce6). The mixed micelles modified with Nimotuzumab (named as NTZ-DCMMs) bind to overexpressed EGFR receptors on Hepatoma-22 (H22) cells. Disulfide bonds in PEG- b -P(GMA- ss -DOX) are disrupted in tumor microenvironment, inducing the reduction-responsive release of DOX and leading to tumor cell apoptosis. Simultaneously, Chlorin e6 (Ce6) produced plenty of singlet oxygen ( 1 O 2 ) under laser irradiation to kill tumor cells. In vivo biological distribution and antineoplastic effect experiments demonstrate that NTZ-DCMMs enhanced drug enrichment at tumor sites through targeting function of antibody, dramatically suppressing tumor growth and mitigating cardiotoxicity of drugs. All results prove that NTZ-DCMMs have the ability to actively target H22 cells and quickly respond to tumor microenvironment, which is expected to become an intelligent and multifunctional drug delivery carrier for efficient chemotherapy and photodynamic therapy of hepatoma. Statement of significance Anticancer drugs used for systemic chemotherapy often exhibit off-target toxicity due to their lack of targeting. Therefore, it's necessary to develop effective, targeted, and collaborative treatment strategies. We construct a mixed micelle of nanomedicine based on two polymer prodrugs and modified with monoclonal antibody on surface for cancer therapy. Under the tumor cell microenvironment, the disulfide bonds of polymer- ss -DOX were broken, effectively triggering DOX release. The photosensitizer Ce6 could generate a large amount of ROS under light, which synergistically promotes tumor cell apoptosis. By coupling antibodies to the hydrophilic segments of polymer micelles, drugs can be specifically delivered. Compared with monotherapy, the combination of chemotherapy and photodynamic therapy can significantly enhance the therapeutic effect of liver cancer.

engineering, biomedical,materials science, biomaterials
Photoacoustic “nanobombs” Fight Against Undesirable Vesicular Compartmentalization of Anticancer Drugs

Aiping Chen,Chun Xu,Min Li,Hailin Zhang,Diancheng Wang,Mao Xia,Gang Meng,Bin Kang,Hongyuan Chen,Jiwu Wei

DOI: https://doi.org/10.1038/srep15527

IF: 4.6

2015-01-01

Scientific Reports

Abstract:Undesirable intracellular vesicular compartmentalization of anticancer drugs in cancer cells is a common cause of chemoresistance. Strategies aimed at circumventing this problem may improve chemotherapeutic efficacy. We report a novel photophysical strategy for controlled-disruption of vesicular sequestration of the anticancer drug doxorubicin (DOX). Single-walled carbon nanotubes (SWCNTs), modified with folate, were trapped in acidic vesicles after entering lung cancer cells. Upon irradiation by near-infrared pulsed laser, these vesicles were massively broken by the resulting photoacoustic shockwave, and the vesicle-sequestered contents were released, leading to redistribution of DOX from cytoplasm to the target-containing nucleus. Redistribution resulted in 12-fold decrease of the EC50 of DOX in lung cancer cells, and enhanced antitumor efficacy of low-dose DOX in tumor-bearing mice. Side effects were not observed. These findings provide insights of using nanotechnology to improve cancer chemotherapy, i.e. not only for drug delivery, but also for overcoming intracellular drug-transport hurdles.
Bone-Targeting Prodrug Mesoporous Silica-Based Nanoreactor with Reactive Oxygen Species Burst for Enhanced Chemotherapy

Fei Tong,Yicheng Ye,Bin Chen,Junbin Gao,Lu Liu,Juanfeng Ou,Jan C. M. van Hest,Shuwen Liu,Fei Peng,Yingfeng Tu

DOI: https://doi.org/10.1021/acsami.0c08992

2020-07-08

Abstract:Cancer remains a primary threat to human lives. Recently, amplification of tumor-associated reactive oxygen species (ROS) has been used as a boosting strategy to improve tumor therapy. Here, we report on a bone-targeting prodrug mesoporous silica-based nanoreactor for combined photodynamic therapy (PDT) and enhanced chemotherapy for osteosarcoma. Because of surface modification of a bone-targeting biphosphate moiety and the enhanced permeability and retention effect, the formed nanoreactor shows efficient accumulation in osteosarcoma and exhibits long-term retention in the tumor microenvironment. Upon laser irradiation, the loaded photosensitizer chlorin e6 (Ce6) produces in situ ROS, which not only works for PDT but also functions as a trigger for controlled release of doxorubicin (DOX) and doxycycline (DOXY) from the prodrugs based on a thioketal (TK) linkage. The released DOXY further promotes ROS production, thus perpetuating subsequent DOX/DOXY release and ROS burst. The ROS amplification induces long-term high oxidative stress, which increases the sensitivity of the osteosarcoma to chemotherapy, therefore resulting in enhanced tumor cell inhibition and apoptosis. The as-developed nanoreactor with combined PDT and enhanced chemotherapy based on ROS amplification shows significant promise as a potential platform for cancer treatment.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c08992?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c08992</a>.1H NMR spectra of TK, DOX-TK, and DOX-TK-DOXY; inverted fluorescence microscopy images and cell apoptosis with TUNEL staining and cell cycle analyses of OS-732 cells; loading contents of Ce6 for /MSN/DOX-TK-DOXY; particle size, UV-vis absorption spectra, and DOX and DOXY release profiles of /MSN/DOX-TK-DOXY; phototriggered intracellular DOX and DOXY release; intracellular ROS production in OS-732 cells; cell apoptosis with TUNEL staining of OS-732 cells treated with /MSN/DOX-TK-DOXY; MTP measurements for /MSN/DOX-TK-DOX; OS-732 cell metabolism after different treatments; body weights of mice bearing OS-732 tumors; ROS analysis in tumor tissues after treatment with /MSN/DOX-TK-DOXY; inner ring tumor microvessel tortuosity and density; HE staining of main organs after treatment; CD31 expression and RT-PCR analyses of tumor vessels; and quantification of DOX and DOXY contents in major organs (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c08992/suppl_file/am0c08992_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

materials science, multidisciplinary,nanoscience & nanotechnology
Light-Activated Monomethyl Auristatin E Prodrug Nanoparticles for Combinational Photo-Chemotherapy of Pancreatic Cancer

In Kyung Cho,Man Kyu Shim,Wooram Um,Jong-Ho Kim,Kwangmeyung Kim

DOI: https://doi.org/10.3390/molecules27082529

IF: 4.6

2022-04-14

Molecules

Abstract:Pancreatic cancer is a highly fatal disease that is becoming an increasingly leading cause of cancer-related deaths. In clinic, the most effective approach to treat pancreatic cancers is the combination treatment of several chemotherapeutic drugs, including fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX), but this approach is not adequate to manage patients due to their severe toxic side effects. Herein, we proposed light-activated monomethyl auristatin E (MMAE) prodrug nanoparticles for combinational photo-chemotherapy and optimized its applications for pancreatic cancer treatment. The photosensitizer (Ce6) and chemotherapeutic drug (MMAE) were conjugated through caspase-3-specific cleavable peptide (KGDEVD). The resulting CDM efficiently promoted the reactive oxygen species (ROS) under visible light irradiation and thereby induced caspase-3 overexpression in pacreatic cancers, which subsequently released the MMAE from the system. Importantly, MMAE released from CDM further amplified the activation of CDM into MMAE by inducing extensive apoptotic cell death in tumor microenvironment for treatment of tumor cells in deep in the tumor tissues as far visible light cannot reach. In addition, CDM formed prodrug nanoparticles via intermolecular π-π stacking and hydrophobic interactions, allowing durable and reliable treatment by preventing fast leakage from the pancreatic cancers via the lymphatic vessels. The CDM directly (intratumoral) injected into pancreatic cancers in orthotopic models through an invasive approach significantly delayed the tumor progression by combinational photo-chemotherapy with less toxic side effects. This study offers a promising and alternative approach for safe and more effective pancreatic cancer treatment via prodrug nanoparticles that combine photodynamic therapy and chemotherapy.

chemistry, multidisciplinary,biochemistry & molecular biology

Nodular scleritis and panuveitis with erythema elevatum diutinum.

Photo and Redox Dual Responsive Reversibly Cross-Linked Nanocarrier for Efficient Tumor-Targeted Drug Delivery

Photodynamic‐Chemodynamic Cascade Reactions for Efficient Drug Delivery and Enhanced Combination Therapy

Dual‐Targeting Photosensitizer‐Peptide Amphiphile Conjugate for Enzyme‐Triggered Drug Delivery and Synergistic Chemo‐Photodynamic Tumor Therapy

Novel construction of multifunctional photo-responsive and nucleic acid-triggered doxorubicin-releasing liposomes for cancer therapy

The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications.

Photo-Responsive Supramolecular Micelles for Controlled Drug Release and Improved Chemotherapy

Photoresponsive Prodrug‐dye Nanoassembly for In‐situ Monitorable Cancer Therapy

Photo Synthesis of Protein-Based Drug-Delivery Nanoparticles for Active Tumor Targeting.

Photosensitizer-stabilized Self-Assembling Nanoparticles Potentiate Chemo/photodynamic Efficacy of Patient-Derived Melanoma.

CD44-Targeted Photoactivatable Polymeric Nanosystem with On-Demand Drug Release as a "Photoactivatable Bomb" for Combined Photodynamic Therapy-Chemotherapy of Cancer

Photon-manipulated Drug Release from a Mesoporous Nanocontainer Controlled by Azobenzene-Modified Nucleic Acid.

MMP-2 and Upconverted UV Dual-Mediated Drug Sequential Delivery and On-Site Immobilization for Enhanced Multidrug-Resistant Cancer Therapy

Dual-responsive Doxorubicin-Loaded Nanomicelles for Enhanced Cancer Therapy.

Acid-sensitive polymeric prodrug micelles for achieving enhanced chemo-photodynamic therapy

Photoactivatable Sequential Destruction of Multiorganelles for Cancer Therapy

Oxidation-strengthened disulfide-bridged prodrug nanoplatforms with cascade facilitated drug release for synergetic photochemotherapy

A Nanomedicine Composed of Polymer- ss -DOX and Polymer-Ce6 Prodrugs with Monoclonal Antibody Targeting Effect for Anti-tumor Chemo-Photodynamic Synergetic Therapy

Photoacoustic “nanobombs” Fight Against Undesirable Vesicular Compartmentalization of Anticancer Drugs

Bone-Targeting Prodrug Mesoporous Silica-Based Nanoreactor with Reactive Oxygen Species Burst for Enhanced Chemotherapy

Light-Activated Monomethyl Auristatin E Prodrug Nanoparticles for Combinational Photo-Chemotherapy of Pancreatic Cancer